Tego Science

At a glance

Tego Science filed 17 disclosures in the last 12 months, including 1 insider and 1 5% holder. The most recent key filing was on Sep 22.

Revenue for 2025 was ₩5.9B, down 12.1% on 2024. It made an operating loss of ₩4.4B. Debt was 55% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩3.2B and operating loss of ₩3B.

The 2025 annual report lists 40 employees with an average tenure of 4.1 years and average pay of ₩48M. Its 5 directors and auditors were paid ₩193.9M each on average. It paid no cash dividend for 2025. 전세화 and related parties held 41.91% at year end.

From the 2025 annual report

Staff: 40 (20 men, 20 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩1.9B. Directors and auditors: 5, paid ₩969.4M in total.

No cash dividend was paid for 2025.

Largest shareholder

전세화 holds 34.31%; with 5 related parties the group holds 41.91% of common shares at year end.

Auditor: 대주회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary